Results 111 to 120 of about 3,785 (146)

A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis

Microbiology and immunology, 2022
This study aimed to compare the efficacy of valaciclovir, valganciclovir, and artesunate in treating chronic reactivated human herpesvirus type 6 (HHV‐6) and human herpesvirus type 7 (HHV‐7) infection associated with myalgic encephalomyelitis/chronic ...
D. Maltsev
semanticscholar   +1 more source

Changes in valganciclovir use among infants with congenital CMV diagnosis in the United States, 2009-2015 and 2016-2019.

Jornal de Pediatria, 2022
From 2009‒2015 to 2016‒2019, the proportion of U.S. infants with congenital cytomegalovirus (cCMV) treated with valganciclovir roughly doubled for infants enrolled with employer-sponsored insurance (from 16% to 29%) and Medicaid (from 16% to 36%).
J. Leung, S. Grosse, K. Hong, Megan H. Pesch, T. Lanzieri   +4 more
semanticscholar   +1 more source

Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in CMV-seronegative recipients of CMV-seropositive donor kidneys Post hoc analysis of a randomized, phase 3 trial of letermovir versus valganciclovir prophylaxis.

American Journal of Transplantation
This post-hoc analysis was conducted to understand the impact of kidney function on 200 days of cytomegalovirus (CMV) prophylaxis in CMV donor-positive/recipient-negative (D+R-) kidney transplant recipients (KTRs).
K. Budde, N. Kamar, Marta Crespo, Catherine B. Small, Nicole Stauffer, Natalya Broyde, Christopher L. Gilbert, Pamela Moise, Barbara Haber   +8 more
semanticscholar   +1 more source

Valganciclovir

Reactions Weekly
  +11 more sources

Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens

Pediatric Transplantation
Valganciclovir is approved for cytomegalovirus prophylaxis in pediatrics using the Pescovitz algorithm. There are reports of valganciclovir overdoses in children with low body surface area and overestimated creatinine clearance utilizing this algorithm ...
Avani K. Patel, Kevin Le, Natalia Panek
semanticscholar   +1 more source

Valganciclovir

Reactions Weekly, 2019
  +7 more sources

Valganciclovir

Reactions Weekly, 2018
  +6 more sources

Valganciclovir

Reactions Weekly, 2023
  +5 more sources

Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study.

Journal of Antimicrobial Chemotherapy, 2023
Adrien Contejean, M. Leruez-Ville, J. Treluyer, V. Tsatsaris, Y. Ville, C. Charlier, L. Chouchana   +6 more
semanticscholar   +1 more source

Valganciclovir

Reactions Weekly, 2020
  +4 more sources